Michael A. Mussallem, Chairman & CEO at Edwards Lifesciences Corp (EW), sold 72,900 shares at $95.39 ($5.7M) on 2022-05-10, disclosed to the SEC on 2022-05-10.
Seasonal sale ($5.7M) by Chairman & CEO — this insider has traded EW in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 12,500 | $0 | 0.0% |
| 2 | $93.41 | 4,700 | $439K | 7.7% |
| 3 | $94.54 | 13,098 | $1.2M | 21.6% |
| 4 | $94.54 | 13,098 | $1.2M | 21.6% |
| 5 | $95.39 | 12,028 | $1.1M | 20.0% |
| 6 | $95.39 | 12,028 |
| $1.1M |
| 20.0% |
| 7 | $96.12 | 2,724 | $262K | 4.6% |
| 8 | $96.12 | 2,724 | $262K | 4.6% |
| Total | $78.66 avg | 72,900 | $5.7M | 100% |
| Filing → |
| EW | SELL | 2024-03-04 | $3.7M | — | Filing → |
| EW | SELL | 2024-02-05 | $5.0M | — | Filing → |
| EW | SELL | 2024-01-05 | $2.3M | — | Filing → |